Abstract:Maintaining blood-brain barrier (BBB) integrity is crucial for the homeostasis of the central nervous system. Structurally comprising the BBB, brain endothelial cells interact with pericytes, astrocytes, neurons, microglia, and perivascular macrophages in the neurovascular unit. Brain ischemia unleashes a profound neuroinflammatory response to remove the damaged tissue and prepare the brain for repair. However, the intense neuroinflammation occurring during the acute phase of stroke is associated with BBB breakdown, neuronal injury, and worse neurological outcomes. Here, we critically discuss the role of neuroinflammation in ischemic stroke pathology, focusing on the BBB and the interactions between central nervous system and peripheral immune responses. We highlight inflammation-driven injury mechanisms in stroke, including oxidative stress, increased MMP (matrix metalloproteinase) production, microglial activation, and infiltration of peripheral immune cells into the ischemic tissue. We provide an updated overview of imaging techniques for in vivo detection of BBB permeability, leukocyte infiltration, microglial activation, and upregulation of cell adhesion molecules following ischemic brain injury. We discuss the possibility of clinical implementation of imaging modalities to assess stroke-associated neuroinflammation with the potential to provide image-guided diagnosis and treatment. We summarize the results from several clinical studies evaluating the efficacy of anti-inflammatory interventions in stroke. Although convincing preclinical evidence suggests that neuroinflammation is a promising target for ischemic stroke, thus far, translating these results into the clinical setting has proved difficult. Due to the dual role of inflammation in the progression of ischemic damage, more research is needed to mechanistically understand when the neuroinflammatory response begins the transition from injury to repair. This could have important implications for ischemic stroke treatment by informing time- and context-specific therapeutic interventions.

Immune Pathways in Etiology, Acute Phase, and Chronic Sequelae of Ischemic Stroke

Systemic immune responses after ischemic stroke: From the center to the periphery

Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches

Immunodepression, Infections, and Functional Outcome in Ischemic Stroke.

Inflammation and Infections as Risk Factors for Ischemic Stroke

Focused Update on Stroke Neuroimmunology: Current Progress in Preclinical and Clinical Research and Recent Mechanistic Insight.

Immunoreactive Cells after Cerebral Ischemia

63. Immune Response in Acute Ischaemic Stroke

Immunothrombosis in Acute Ischemic Stroke

Inflammatory mechanisms in ischemic stroke: therapeutic approaches

Contribution of the immune response to stroke provides promising directions for future stroke immunotherapies

Role of DAMPs and of Leukocytes Infiltration in Ischemic Stroke: Insights from Animal Models and Translation to the Human Disease

Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial Cells

Ischemic Stroke and Immune Reaction

Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities.

Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?

Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections

Drivers of Chronic Pathology Following Ischemic Stroke: A Descriptive Review

Immune regulation of the gut-brain axis and lung-brain axis involved in ischemic stroke

Inflammation in stroke and focal cerebral ischemia